SYMTHERA CANADA LTD.
5Patents
5Active
5Granted
44Portfolio score
Filing activity: Mar 18, 2007 → Oct 30, 2020 · 1 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9416158B2 | Cytokine receptor peptides, compositions thereof and methods thereof | Emerging Cross-Sectional Technologies | 1 | Active |
| US9931376B2 | Cytokine receptor peptides, compositions thereof and methods thereof | Emerging Cross-Sectional Technologies | 1 | Active |
| US8703911B2 | Cytokine receptor peptides, compositions thereof and methods thereof | Emerging Cross-Sectional Technologies | 1 | Active |
| US11078255B2 | Ca2+ regulated binding agents | Physics | 0 | Active |
| US11926677B2 | Peptides and uses thereof for treating cancer | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.